Department of Obstetrics and Gynecology

139_OB/GYN ULTRASOUND, PRENATAL DIAGNOSIS, & GENETICS GRAND ROUNDS

Friday, August 25, 2023

12 noon to 1 pm

Team’s Meeting

Dr. Hawkins, MD/UT Southwestern

Fetal CNS II

Course Director:  Patricia Santiago-Munoz,  MD

Purpose and Content

With advances in obstetrical sonography and prenatal diagnosis, a forum is needed to discuss antenatal and neonatal management of fetuses with anomalies.  Presentations include lectures, case studies, and small group discussions.

Target Audience

Physicians (Obstetrics & Gynecology, Maternal-Fetal Medicine, Neonatology, Radiology, Cytogenetics, Pediatric Surgery, and Pediatric Cardiology), UT Southwestern Faculty, Residents, Fellows, Community Physicians, Sonographers, Genetic Counselors and Nurse Clinicians.

Educational Objectives

At the conclusion of this activity, the participant should be able to:

1.     Improved ability to interpret abnormal ultrasounds.

2.     Improved ability to formulate management plans for pregnancies complicated by fetal anomalies, involving therapy as appropriate.

Educational Method

Slide format, Didactic presentation with discussion of cases

Accreditation:  The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:  The University of Texas Southwestern Medical Center designates this live activity for a maximum of
1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Relevant Financial Relationships:  In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accrediting Continuing Education, all persons in the position to control the content of an education activity are required to disclose all financial relationships in any amount occurring within the past 24 months with any ineligible company (any entity whose primary business is producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients).  UT Southwestern also considers ineligible those companies producing, marketing, selling, re-selling, or distributing healthcare products in development for future use on patients, such as healthcare product research companies. All reported financial relationships with ineligible companies are reviewed for relevancy and then mitigated through a content review process prior to the activity (where applicable).